Skip to main content
Top
Published in: Urolithiasis 1/2019

01-02-2019 | Invited Review

Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms

Authors: Giovanni Gambaro, G. Zaza, F. Citterio, A. Naticchia, P. M. Ferraro

Published in: Urolithiasis | Issue 1/2019

Login to get access

Abstract

Deciding whether to accept a donor with nephrolithiasis is a multifaceted task because of the challenge of finding enough suitable donors while at the same time ensuring the safety of both donors and recipients. Until not long ago, donors with a history of renal stones or with stones emerging during screening on imaging were not considered ideal, but recent guidelines have adopted less stringent criteria for potential donors at risk of stones. This review goes through the problems that need to be approached to arrive at a wise clinical decision, balancing the safety of donors and recipients with the need to expand the organ pool. The risk of declining renal function and worsening stone formation is examined. Documents (consensus statements, guidelines, etc.) on this issue released by the most important medical societies and organizations are discussed and compared. Specific problems of living kidney donation associated with certain systemic (chronic hypercalcemia due to CYP24A1 gene mutations, primary hyperoxaluria, APRT deficiency) and renal (medullary sponge kidney, cystinuria, distal renal tubular acidosis, Dent’s disease, Bartter syndrome, familial hypomagnesemia with hypercalciuria and nephrocalcinosis) Mendelian disorders that cause nephrolithiasis are also addressed.
Literature
1.
go back to reference Croppi E, Ferraro PM, Taddei L, Gambaro G, GEA Firenze Study Group (2012) Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res 40(5):517–522CrossRef Croppi E, Ferraro PM, Taddei L, Gambaro G, GEA Firenze Study Group (2012) Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res 40(5):517–522CrossRef
2.
go back to reference Lorenz EC, Lieske JC, Vrtiska TJ, Krambeck AE, Li X, Bergstralh EJ, Melton LJ 3rd, Rule AD (2011) Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 26(8):2695–2700CrossRef Lorenz EC, Lieske JC, Vrtiska TJ, Krambeck AE, Li X, Bergstralh EJ, Melton LJ 3rd, Rule AD (2011) Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 26(8):2695–2700CrossRef
3.
go back to reference Olsburgh J, Thomas K, Wong K, Bultitude M, Glass J, Rottenberg G, Silas L, Hilton R, Koffman G (2013) Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int 111(5):784–792CrossRef Olsburgh J, Thomas K, Wong K, Bultitude M, Glass J, Rottenberg G, Silas L, Hilton R, Koffman G (2013) Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int 111(5):784–792CrossRef
4.
go back to reference Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX, Chronic Kidney Disease Prognosis Consortium (2016) Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374(5):411–421CrossRef Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX, Chronic Kidney Disease Prognosis Consortium (2016) Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374(5):411–421CrossRef
5.
go back to reference Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M, Alberta Kidney Disease Network (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287CrossRef Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M, Alberta Kidney Disease Network (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287CrossRef
6.
go back to reference El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415CrossRef El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415CrossRef
7.
go back to reference Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198(2):268–273CrossRef Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198(2):268–273CrossRef
8.
go back to reference Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64(6):2204–2213CrossRef Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64(6):2204–2213CrossRef
9.
go back to reference Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich A, Schuler B, Tong L, Baker LA (2010) Hospitalizations for pediatric stone disease in United States, 2002–2007. J Urol 183(3):1151–1156CrossRef Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich A, Schuler B, Tong L, Baker LA (2010) Hospitalizations for pediatric stone disease in United States, 2002–2007. J Urol 183(3):1151–1156CrossRef
10.
go back to reference Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168(1):27–30CrossRef Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168(1):27–30CrossRef
11.
go back to reference Lee YH, Huang WC, Chang LS, Chen MT, Yang YF, Huang JK (1994) The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. J Urol 152:1386–1388CrossRef Lee YH, Huang WC, Chang LS, Chen MT, Yang YF, Huang JK (1994) The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. J Urol 152:1386–1388CrossRef
12.
go back to reference Ferraro PM, Curhan GC, D’Addessi A, Gambaro G (2017) Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol 30(2):227–233CrossRef Ferraro PM, Curhan GC, D’Addessi A, Gambaro G (2017) Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol 30(2):227–233CrossRef
13.
go back to reference Kim IK, Tan JC, Lapasia J, Elihu A, Busque S, Melcher ML (2012) Incidental kidney stones: a single center experience with kidney donor selection. Clin Transpl 26(4):558–563CrossRef Kim IK, Tan JC, Lapasia J, Elihu A, Busque S, Melcher ML (2012) Incidental kidney stones: a single center experience with kidney donor selection. Clin Transpl 26(4):558–563CrossRef
14.
go back to reference Rizkala E, Coleman S, Tran C, Isac W, Flechner SM, Goldfarb D, Monga M (2013) Stone disease in living-related renal donors: long-term outcomes for transplant donors and recipients. J Endourol 27(12):1520–1524CrossRef Rizkala E, Coleman S, Tran C, Isac W, Flechner SM, Goldfarb D, Monga M (2013) Stone disease in living-related renal donors: long-term outcomes for transplant donors and recipients. J Endourol 27(12):1520–1524CrossRef
15.
go back to reference Serur D, Charlton M, Juluru K, Salama G, Locastro E, Bretzlaff G, Hartono C (2017) Long-term follow-up of kidney donors with asymptomatic renal stones. Nephrology (Carlton) 22(8):649–651CrossRef Serur D, Charlton M, Juluru K, Salama G, Locastro E, Bretzlaff G, Hartono C (2017) Long-term follow-up of kidney donors with asymptomatic renal stones. Nephrology (Carlton) 22(8):649–651CrossRef
16.
go back to reference Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014) Familial clustering of ESRD in the Norwegian population. Clin J Am Soc Nephrol 9(10):1692–1700CrossRef Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014) Familial clustering of ESRD in the Norwegian population. Clin J Am Soc Nephrol 9(10):1692–1700CrossRef
17.
go back to reference Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O, Abramowicz D, ERA-EDTA DESCARTES Working Group (2017) Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES Working Group. Nephrol Dial Transpl 32(2):216–223CrossRef Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O, Abramowicz D, ERA-EDTA DESCARTES Working Group (2017) Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES Working Group. Nephrol Dial Transpl 32(2):216–223CrossRef
18.
go back to reference Delmonico F, Council of the Transplantation Society (2005) A report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation 79(6 Suppl):S53–S66PubMed Delmonico F, Council of the Transplantation Society (2005) A report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation 79(6 Suppl):S53–S66PubMed
19.
go back to reference Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM (1996) The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 7(11):2288–2313PubMed Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM (1996) The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 7(11):2288–2313PubMed
20.
go back to reference European Renal Best Practice Transplantation Guideline Development Group (2013) ERBP Guideline on the management and evaluation of the kidney donor and recipient. Nephrol Dial Transpl 28(Suppl 2):ii1–i71CrossRef European Renal Best Practice Transplantation Guideline Development Group (2013) ERBP Guideline on the management and evaluation of the kidney donor and recipient. Nephrol Dial Transpl 28(Suppl 2):ii1–i71CrossRef
21.
go back to reference Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX (2017) KDIGO Clinical Practice Guideline on the evaluation and care of living kidney donors. Transplantation 101(8S Suppl 1):S1–S109PubMed Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX (2017) KDIGO Clinical Practice Guideline on the evaluation and care of living kidney donors. Transplantation 101(8S Suppl 1):S1–S109PubMed
23.
go back to reference Gambaro G, Reis-Santos JM, Rao N (2004) Nephrolithiasis: why doesn’t our “learning”. progress? Eur Urol 45(5):547–556CrossRef Gambaro G, Reis-Santos JM, Rao N (2004) Nephrolithiasis: why doesn’t our “learning”. progress? Eur Urol 45(5):547–556CrossRef
24.
go back to reference Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734CrossRef Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734CrossRef
25.
go back to reference Rule AD, Lieske JC, Li X, Melton LJ 3rd, Krambeck AE, Bergstralh EJ (2014) The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 25(12):2878–2886CrossRef Rule AD, Lieske JC, Li X, Melton LJ 3rd, Krambeck AE, Bergstralh EJ (2014) The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 25(12):2878–2886CrossRef
27.
go back to reference Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Akhtar F, Zafar MN, Hussain M, Ahmed E, Kazi JI, Hasan AS, Khalid R, Aziz S, Sultan S (2002) Living-related pediatric renal transplants: a single-center experience from a developing country. Pediatr Transpl 6(2):101–110CrossRef Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Akhtar F, Zafar MN, Hussain M, Ahmed E, Kazi JI, Hasan AS, Khalid R, Aziz S, Sultan S (2002) Living-related pediatric renal transplants: a single-center experience from a developing country. Pediatr Transpl 6(2):101–110CrossRef
28.
go back to reference Riese RJ, Sakhaee K (1992) Uric acid nephrolithiasis: pathogenesis and treatment. J Urol 148(3):765–771CrossRef Riese RJ, Sakhaee K (1992) Uric acid nephrolithiasis: pathogenesis and treatment. J Urol 148(3):765–771CrossRef
29.
go back to reference Moe OW, Xu LHR (2018) Hyperuricosuric calcium urolithiasis. J Nephrol 31(2):189–196CrossRef Moe OW, Xu LHR (2018) Hyperuricosuric calcium urolithiasis. J Nephrol 31(2):189–196CrossRef
30.
go back to reference O’Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA (2016) Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int 27(10):3121–3125CrossRef O’Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA (2016) Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int 27(10):3121–3125CrossRef
31.
go back to reference Ferraro PM, Minucci A, Primiano A, De Paolis E, Gervasoni J, Persichilli S, Naticchia A, Capoluongo E, Gambaro G (2017) A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass. Urolithiasis 45(3):291–294CrossRef Ferraro PM, Minucci A, Primiano A, De Paolis E, Gervasoni J, Persichilli S, Naticchia A, Capoluongo E, Gambaro G (2017) A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass. Urolithiasis 45(3):291–294CrossRef
33.
go back to reference Hoppe B, Beck BB, Milliner DS (2009) The primary hyperoxalurias. Kidney Int 75:1264–1271CrossRef Hoppe B, Beck BB, Milliner DS (2009) The primary hyperoxalurias. Kidney Int 75:1264–1271CrossRef
34.
go back to reference Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N (1995) Epidemiology of primary hyperoxaluria type 1. Société de Néphrologie and the Société de Néphrologie Pédiatrique. Nephrol Dial Transplant 10(Suppl 8):3–7CrossRef Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N (1995) Epidemiology of primary hyperoxaluria type 1. Société de Néphrologie and the Société de Néphrologie Pédiatrique. Nephrol Dial Transplant 10(Suppl 8):3–7CrossRef
35.
go back to reference Nanmoku K, Kurosawa A, Shinzato T, Shimizu T, Kimura T, Yagisawa T (2017) Febuxostat for the prevention of recurrent 2,8-dihydroxyadenine nephropathy due to adenine phosphoribosyltransferase deficiency following kidney transplantation. Intern Med 56(11):1387–1391CrossRef Nanmoku K, Kurosawa A, Shinzato T, Shimizu T, Kimura T, Yagisawa T (2017) Febuxostat for the prevention of recurrent 2,8-dihydroxyadenine nephropathy due to adenine phosphoribosyltransferase deficiency following kidney transplantation. Intern Med 56(11):1387–1391CrossRef
37.
go back to reference Mohebbi N, Ferraro PM, Gambaro G, Unwin R (2017) Tubular and genetic disorders associated with kidney stones. Urolithiasis 45(1):127–137CrossRef Mohebbi N, Ferraro PM, Gambaro G, Unwin R (2017) Tubular and genetic disorders associated with kidney stones. Urolithiasis 45(1):127–137CrossRef
38.
go back to reference Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, Gambaro G (2010) Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol 5(9):1663–1668CrossRef Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, Gambaro G (2010) Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol 5(9):1663–1668CrossRef
39.
go back to reference Gambaro G, Goldfarb DS, Baccaro R, Hirsch J, Topilow N, D’Alonzo S, Gambassi G, Ferraro PM (2018) Chronic pain in medullary sponge kidney: a rare and never described clinical presentation. J Nephrol 31(4):537–542CrossRef Gambaro G, Goldfarb DS, Baccaro R, Hirsch J, Topilow N, D’Alonzo S, Gambassi G, Ferraro PM (2018) Chronic pain in medullary sponge kidney: a rare and never described clinical presentation. J Nephrol 31(4):537–542CrossRef
40.
go back to reference Fabris A, Anglani F, Lupo A, Gambaro G (2013) Medullary sponge kidney: state of the art. Nephrol Dial Transpl 28(5):1111–1119CrossRef Fabris A, Anglani F, Lupo A, Gambaro G (2013) Medullary sponge kidney: state of the art. Nephrol Dial Transpl 28(5):1111–1119CrossRef
41.
go back to reference Fabris A, Lupo A, Ferraro PM, Anglani F, Pei Y, Danza FM, Gambaro G (2013) Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int 83(2):272–277CrossRef Fabris A, Lupo A, Ferraro PM, Anglani F, Pei Y, Danza FM, Gambaro G (2013) Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int 83(2):272–277CrossRef
42.
go back to reference Ria P, Fabris A, Dalla Gassa A, Zaza G, Lupo A, Gambaro G (2017) New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. Urolithiasis 45(4):359–362CrossRef Ria P, Fabris A, Dalla Gassa A, Zaza G, Lupo A, Gambaro G (2017) New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. Urolithiasis 45(4):359–362CrossRef
43.
go back to reference Gambaro G, Danza FM, Fabris A (2013) Medullary sponge kidney. Curr Opin Nephrol Hypertens 22(4):421–426CrossRef Gambaro G, Danza FM, Fabris A (2013) Medullary sponge kidney. Curr Opin Nephrol Hypertens 22(4):421–426CrossRef
44.
go back to reference Cheungpasitporn W, Thongprayoon C, Brabec BA, Kittanamongkolchai W, Erickson SB (2016) Outcomes of living kidney donors with medullary sponge kidney. Clin Kidney J 9(6):866–870CrossRef Cheungpasitporn W, Thongprayoon C, Brabec BA, Kittanamongkolchai W, Erickson SB (2016) Outcomes of living kidney donors with medullary sponge kidney. Clin Kidney J 9(6):866–870CrossRef
45.
go back to reference Gambaro G et al (2012) Re: McPhail Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology 80:1395–1396 (Urology 2012 79(6):277–281) CrossRef Gambaro G et al (2012) Re: McPhail Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology 80:1395–1396 (Urology 2012 79(6):277–281) CrossRef
46.
go back to reference Ferraro PM, D’Addessi A, Gambaro G (2013) When to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dial Transpl 28(4):811–820CrossRef Ferraro PM, D’Addessi A, Gambaro G (2013) When to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dial Transpl 28(4):811–820CrossRef
48.
go back to reference Tuso P, Barnett M, Yasunaga C, Nortman D (1993) Cystinuria and renal transplantation. Nephron 63(4):478CrossRef Tuso P, Barnett M, Yasunaga C, Nortman D (1993) Cystinuria and renal transplantation. Nephron 63(4):478CrossRef
49.
go back to reference Rhodes HL, Yarram-Smith L, Rice SJ, Tabaksert A, Edwards N, Hartley A, Woodward MN, Smithson SL, Tomson C, Welsh GI, Williams M, Thwaites DT, Sayer JA, Coward RJ (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol 10(7):1235–1245CrossRef Rhodes HL, Yarram-Smith L, Rice SJ, Tabaksert A, Edwards N, Hartley A, Woodward MN, Smithson SL, Tomson C, Welsh GI, Williams M, Thwaites DT, Sayer JA, Coward RJ (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol 10(7):1235–1245CrossRef
50.
go back to reference Mohebbi N, Wagner CA (2018) Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol 31(4):511–522CrossRef Mohebbi N, Wagner CA (2018) Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol 31(4):511–522CrossRef
52.
go back to reference Zhang J, Fuster DG, Cameron MA, Quinones H, Griffith C, Xie XS, Moe OW (2014) Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit. Am J Physiol Renal Physiol 307(9):F1063–F1071CrossRef Zhang J, Fuster DG, Cameron MA, Quinones H, Griffith C, Xie XS, Moe OW (2014) Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit. Am J Physiol Renal Physiol 307(9):F1063–F1071CrossRef
53.
go back to reference Dhayat NA, Schaller A, Albano G, Poindexter J, Griffith C, Pasch A, Gallati S, Vogt B, Moe OW, Fuster DG (2016) The vacuolar H+-ATPase B1 subunit polymorphism p.E161K associates with impaired urinary acidification in recurrent stone formers. J Am Soc Nephrol 27(5):1544–1554CrossRef Dhayat NA, Schaller A, Albano G, Poindexter J, Griffith C, Pasch A, Gallati S, Vogt B, Moe OW, Fuster DG (2016) The vacuolar H+-ATPase B1 subunit polymorphism p.E161K associates with impaired urinary acidification in recurrent stone formers. J Am Soc Nephrol 27(5):1544–1554CrossRef
54.
go back to reference Sromicki JJ, Hess B (2017) Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment. Urolithiasis 45(3):263–269CrossRef Sromicki JJ, Hess B (2017) Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment. Urolithiasis 45(3):263–269CrossRef
55.
go back to reference Carvalho M, Erbano BO, Kuwaki EY, Pontes HP, Liu JWTW, Boros LH, Asinelli MO, Baena CP (2017) Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis. Urolithiasis 45(5):449–455CrossRef Carvalho M, Erbano BO, Kuwaki EY, Pontes HP, Liu JWTW, Boros LH, Asinelli MO, Baena CP (2017) Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis. Urolithiasis 45(5):449–455CrossRef
56.
go back to reference Wrong OM, Norden AG, Feest TG (1994) Dent’s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493PubMed Wrong OM, Norden AG, Feest TG (1994) Dent’s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493PubMed
57.
go back to reference Gambaro G, Naticchia A, Ferraro PM, Romagnoli J, Salerno MP, Citterio F. Living kidney donation in a type 1 Dent’s disease patient from his mother (submitted) Gambaro G, Naticchia A, Ferraro PM, Romagnoli J, Salerno MP, Citterio F. Living kidney donation in a type 1 Dent’s disease patient from his mother (submitted)
58.
go back to reference Chaudhuri A, Salvatierra O Jr, Alexander SR, Sarwal MM (2006) Option of pre-emptive nephrectomy and renal transplantation for Bartter’s syndrome. Pediatr Transpl 10(2):266–270CrossRef Chaudhuri A, Salvatierra O Jr, Alexander SR, Sarwal MM (2006) Option of pre-emptive nephrectomy and renal transplantation for Bartter’s syndrome. Pediatr Transpl 10(2):266–270CrossRef
59.
go back to reference Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425CrossRef Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425CrossRef
60.
go back to reference Arteaga ME, Hunziker W, Teo AS, Hillmer AM, Mutchinick OM (2015) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry. Ren Fail 37(1):180–183CrossRef Arteaga ME, Hunziker W, Teo AS, Hillmer AM, Mutchinick OM (2015) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry. Ren Fail 37(1):180–183CrossRef
61.
go back to reference Almeida JR, Machado Gde A, dos Santos MM, Lopes Pde F, de Matos JP, Neves AC, Lugon JR (2014) Five years results after intrafamilial kidney post-transplant in a case of familial hypomagnesemia due to a claudin-19 mutation. J Bras Nefrol 36(3):401–405CrossRef Almeida JR, Machado Gde A, dos Santos MM, Lopes Pde F, de Matos JP, Neves AC, Lugon JR (2014) Five years results after intrafamilial kidney post-transplant in a case of familial hypomagnesemia due to a claudin-19 mutation. J Bras Nefrol 36(3):401–405CrossRef
62.
go back to reference Giessing M, Fuller F, Tuellmann M, Liefeld L, Slowinski T, Budde K, Loening SA (2008) Attitude to nephrolithiasis in the potential living kidney donor: a survey of the German kidney transplant centers and review of the literature. Clin Transpl 22(4):476–483CrossRef Giessing M, Fuller F, Tuellmann M, Liefeld L, Slowinski T, Budde K, Loening SA (2008) Attitude to nephrolithiasis in the potential living kidney donor: a survey of the German kidney transplant centers and review of the literature. Clin Transpl 22(4):476–483CrossRef
Metadata
Title
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms
Authors
Giovanni Gambaro
G. Zaza
F. Citterio
A. Naticchia
P. M. Ferraro
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 1/2019
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1092-4

Other articles of this Issue 1/2019

Urolithiasis 1/2019 Go to the issue